👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

New virus wave, Volvo warning drag European stocks lower

Published 03/23/2021, 04:22 AM
Updated 03/23/2021, 05:50 AM
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt
DE40
-
EZJ
-
ICAG
-
STOXX
-

By Sruthi Shankar

(Reuters) - European stocks eased from a one-year peak on Tuesday, as a new wave of coronavirus infection and fresh lockdown in Germany raised fears of a slow economic recovery from the pandemic shock.

The pan-European STOXX 600 index fell 0.4% after a new round of sanctions aimed at China hit Asian markets.

The German DAX dropped 0.4% after Chancellor Angela Merkel on Tuesday decided to extend lockdown until April 18 and called on citizens to stay at home for five days over the Easter holidays.

Swedish truckmaker Volvo slumped 6.4% after it warned that a shortage of semiconductors would have a substantial impact on production in the second quarter.

Its stock weighed on Europe's industrial goods and services sector , while automakers slid 1.8% to give back some of their recent gains.

"The market is taking the view that recovery is going to be delayed because things are not getting better for the time being," said Emmanuel Cau, head of European equity strategy at Barclays (LON:BARC).

"But as long as the vaccine efficacy is not being put into question, we think investors will look through short-term volatility."

The STOXX 600 last week climbed to their highest level since February, recouping most of the pandemic-driven losses on hopes that vaccination drives and stimulus measures will spur a strong economic rebound.

The gains have slowed this week amid worries about a surge in COVID-19 cases. The tally of new cases in France accelerated despite the start of a third lockdown, while Austria postponed the reopening of cafe and restaurants.

Travel & leisure stocks fell again, with British Airways-owner IAG (LON:ICAG), easyJet (LON:EZJ) and travel company TUI down more than 4%.

British Health minister Matt Hancock said fines of 5,000 pounds ($6,900) will be introduced for people from England who try to travel abroad before the end of June.

Swiss drugmaker Roche fell 1.2% after it dropped a late-stage trial of its Huntington's disease hopeful, tominersen.

Swiss online pharmacy chain Zur Rose surged to the top of STOXX 600 after Morgan Stanley (NYSE:MS) started coverage with an "overweight" rating.

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt

Shares in online reviews platform Trustpilot jumped 14% in their London stock market debut. The company priced the IPO at 265 pence per share, giving it a market capitalisation of 1.08 billion pounds ($1.49 billion).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.